These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 18786842)

  • 1. Prostate cancer in dogs: comparative and clinical aspects.
    Leroy BE; Northrup N
    Vet J; 2009 May; 180(2):149-62. PubMed ID: 18786842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine prostatic intraepithelial neoplasia: is the comparative model relevant?
    Madewell BR; Gandour-Edwards R; DeVere White RW
    Prostate; 2004 Feb; 58(3):314-7. PubMed ID: 14743472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer in dogs and men: a unique opportunity to study the disease.
    Argyle DJ
    Vet J; 2009 May; 180(2):137-8. PubMed ID: 18835203
    [No Abstract]   [Full Text] [Related]  

  • 4. Polysomy 13 in a canine prostate carcinoma underlining its significance in the development of prostate cancer.
    Winkler S; Reimann-Berg N; Murua Escobar H; Loeschke S; Eberle N; Höinghaus R; Nolte I; Bullerdiek J
    Cancer Genet Cytogenet; 2006 Sep; 169(2):154-8. PubMed ID: 16938574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pathology of benign prostatic hyperplasia and prostate cancer.
    Maini A; Archer C; Wang CY; Haas GP
    In Vivo; 1997; 11(4):293-9. PubMed ID: 9292295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population study of neutering status as a risk factor for canine prostate cancer.
    Bryan JN; Keeler MR; Henry CJ; Bryan ME; Hahn AW; Caldwell CW
    Prostate; 2007 Aug; 67(11):1174-81. PubMed ID: 17516571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model.
    Waters DJ; Shen S; Glickman LT; Cooley DM; Bostwick DG; Qian J; Combs GF; Morris JS
    Carcinogenesis; 2005 Jul; 26(7):1256-62. PubMed ID: 15817614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using surrogate biomarkers to predict clinical benefit in men with castration-resistant prostate cancer: an update and review of the literature.
    Armstrong AJ; Febbo PG
    Oncologist; 2009 Aug; 14(8):816-27. PubMed ID: 19684076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen deprivation therapy for advanced prostate cancer: why does it fail and can its effects be prolonged?
    Singer EA; Golijanin DJ; Messing EM
    Can J Urol; 2008 Dec; 15(6):4381-7. PubMed ID: 19046491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of angiostatin in the spontaneous bone and prostate cancers of pet dogs.
    Pirie-Shepherd SR; Coffman KT; Resnick D; Chan R; Kisker O; Folkman J; Waters DJ
    Biochem Biophys Res Commun; 2002 Apr; 292(4):886-91. PubMed ID: 11944897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual prostatic mass in a dog.
    Gilson SD; Miller RT; Hardie EM; Spaulding KA
    J Am Vet Med Assoc; 1992 Mar; 200(5):702-4. PubMed ID: 1373709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a cell line derived from a canine prostate carcinoma with a highly rearranged karyotype.
    Winkler S; Murua Escobar H; Eberle N; Reimann-Berg N; Nolte I; Bullerdiek J
    J Hered; 2005; 96(7):782-5. PubMed ID: 15994418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine prostatic disease: a review of anatomy, pathology, diagnosis, and treatment.
    Smith J
    Theriogenology; 2008 Aug; 70(3):375-83. PubMed ID: 18514299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases.
    Cornell KK; Bostwick DG; Cooley DM; Hall G; Harvey HJ; Hendrick MJ; Pauli BU; Render JA; Stoica G; Sweet DC; Waters DJ
    Prostate; 2000 Oct; 45(2):173-83. PubMed ID: 11027417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the biology of bone metastases: key to the effective treatment of prostate cancer.
    Logothetis CJ; Navone NM; Lin SH
    Clin Cancer Res; 2008 Mar; 14(6):1599-602. PubMed ID: 18347159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distribution of oestrogen receptors in normal, hyperplastic and neoplastic canine prostate, as demonstrated immunohistochemically.
    Grieco V; Riccardi E; Rondena M; Romussi S; Stefanello D; Finazzi M
    J Comp Pathol; 2006 Jul; 135(1):11-6. PubMed ID: 16815431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research prostate carcinoma in the dog at the University Clinic for Companion Animals in Utrecht, the Netherlands].
    L'Eplattenier H
    Tijdschr Diergeneeskd; 2003 Feb; 128(4):120-1. PubMed ID: 12625160
    [No Abstract]   [Full Text] [Related]  

  • 19. Conventional treatments of localized prostate cancer.
    Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
    Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine prostatic disease--comparison of ultrasonographic appearance with morphologic and microbiologic findings: 30 cases (1981-1985).
    Feeney DA; Johnston GR; Klausner JS; Perman V; Leininger JR; Tomlinson MJ
    J Am Vet Med Assoc; 1987 Apr; 190(8):1027-34. PubMed ID: 3553121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.